All In Biotech

Drug Trial Radar · NCT03250598

Study to Evaluate the Pharmacokinetics, Safety, and QTc Effect of AG-348 in Healthy Subjects of Japanese Origin and Non-Asian Origin

A Phase 1, Single-Dose, Open-Label Study to Characterize and Compare the Pharmacokinetics, Safety, and Effect on QTc Interval of AG-348 in Healthy Subjects of Japanese Origin and Healthy Subjects of Non-Asian Origin

Last checked: Nov 19, 2026Latest source record: Oct 19, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

60

Actual

Start

Aug 9, 2017

Primary completion

Oct 2, 2017

Study completion Oct 9, 2017

Sponsor

Lead sponsor
Agios Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Aug 15, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this Phase I, single-dose, open-label trial is to evaluate the pharmacokinetics, safety, and effect on QTc interval of AG-348 in healthy, adult Japanese and Non-Asian subjects. The study plans to evaluate 3 cohorts of a single oral dose of AG-348 in Japanese and Non-Asian subjects. Pharmacokinetic sampling will take place serially at specified times during conduct of the study.

Conditions

  • Healthy
  • Japanese
  • Non-Asian

Interventions

  • AG-348Drug

    50 mg single-dose

  • AG-348Drug

    5 mg single-dose

  • AG-348Drug

    200 mg single-dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. AUCTime frame: Pharmacokinetic sampling for AG-348 will be taken for 72 hours (4 days) after single dose
  2. CmaxTime frame: Pharmacokinetic sampling for AG-348 will be taken for 72 hours (4 days) after single dose

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • West Coast Clinical Trial (WCCT) Global, Inc.

    Cypress, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.